SER Serina Therapeutics Inc.

Price (delayed)

$2.19

Market cap

$55.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.89

Enterprise value

$35.81M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 0
Highlights
The quick ratio has surged by 58% since the previous quarter
The equity is up by 6% since the previous quarter
The company's EPS has shrunk by 50% YoY but it rose by 6% QoQ
Serina Therapeutics's gross profit has shrunk by 100% QoQ and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Key stats

What are the main financial stats of SER

SER stock price

How has the Serina Therapeutics stock price performed over time
Intraday
-5.19%
1 week
1.39%
1 month
-23.69%
1 year
-56.29%
YTD
14.48%
QTD
12.89%

Financial performance

How have Serina Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.66M
Net income
-$21.18M
Gross margin
N/A
Net margin
N/A
Serina Therapeutics's gross profit has shrunk by 100% QoQ and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
The net income has dropped by 68% year-on-year
The company's operating income fell by 15% YoY and by 5% QoQ

Price vs fundamentals

How does SER's price correlate with its fundamentals

Growth

What is Serina Therapeutics's growth rate over time

Valuation

What is Serina Therapeutics stock price valuation
P/E
N/A
P/B
1.75
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 50% YoY but it rose by 6% QoQ
The equity is up by 6% since the previous quarter
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Serina Therapeutics business performance
The ROIC has soared by 81% QoQ but it fell by 20% YoY
Serina Therapeutics's ROE has increased by 38% from the previous quarter
Serina Therapeutics's ROA has increased by 22% YoY and by 15% from the previous quarter

Dividends

What is SER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SER.

Financial health

How did Serina Therapeutics financials performed over time
The company's current ratio has surged by 197% YoY and by 59% QoQ
Serina Therapeutics's total assets has surged by 189% YoY but it has decreased by 5% QoQ
The company's debt is 83% lower than its equity
The debt to equity has surged by 70% year-on-year but it has declined by 6% since the previous quarter
The equity is up by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.